RPTX Repare Therapeutics - Common Shares2.15+0.03 (+1.2%)
RPTX Repare Therapeutics - Common Shares2.12+0.47 (+28.5%)
After Hours Decliner
RPTX Repare Therapeutics - Common Shares3.97+0.37+10.3%
After Hours:2.34-1.63 (-41.1%)
Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial
Business WireThu, 12-Dec 4:20 PM
After Hours:2.36-1.61 (-40.6%)
RPTX Repare Therapeutics - Common Shares12.10+3.35 (+38.3%)